John Wiley Sons B 2026 Q1 Earnings Profitable Turnaround with 914.8% Net Income Growth
Generated by AI AgentAinvest Earnings Report Digest
Thursday, Sep 4, 2025 9:15 pm ET2min read
WLYB--
Aime Summary
John Wiley & Sons BWLYB-- (WLYB) reported its fiscal 2026 Q1 earnings on September 4, 2025, with the company returning to profitability and reaffirming its full-year outlook.
John Wiley & Sons B delivered a strong earnings surprise, posting a net income of $11.70 million in Q1 2026 compared to a net loss of $1.44 million in the same period the prior year. The company also reported positive EPS of $0.22, reversing its prior-year loss of $0.03 per share. While total revenue declined slightly by 1.7% year-over-year to $396.80 million, management remains confident in its 2026 guidance, citing strong demand in AI and R&D-driven research and continued cost efficiencies.
Revenue
Total revenue for John Wiley & Sons BWLYB-- declined by 1.7% to $396.80 million in Q1 2026, compared to $403.81 million in Q1 2025.
Earnings/Net Income
John Wiley & Sons B returned to profitability in Q1 2026, reporting an EPS of $0.22, up from a loss of $0.03 per share in the prior-year period, representing an 833.3% positive change. The company also achieved a significant net income of $11.70 million, a 914.8% increase from the net loss of $1.44 million in Q1 2025, marking a strong operational turnaround.
Price Action
The stock price of John Wiley & Sons B has edged down 0.00% during the latest trading day, declined 1.05% over the most recent full trading week, and gained 2.95% month-to-date.
Post-Earnings Price Action Review
Following the earnings release, the stock demonstrated mixed price movement in the short term. Although the company delivered a strong earnings turnaround, the stock remained flat in the most recent trading day and dipped slightly during the week. However, it has shown resilience with a 2.95% gain over the past month, suggesting investor confidence in the company's strategic direction and financial recovery.
CEO Commentary
Matthew Kissner, President and CEO, emphasized the company’s strong position in the AI and R&D research sectors, highlighting Wiley’s leadership in AI licensing and a landmark AI project with a large tech company. He also noted a strategic partnership with Anthropic and key operational milestones, including successful platform launches and AI integrations. Kissner expressed confidence in the company's Fiscal 2026 outlook, citing strong demand indicators, recurring revenue growth, and ongoing cost savings as key drivers.
Guidance
Wiley reaffirmed its Fiscal 2026 outlook, citing strong demand, positive output indicators, successful 2025 journal renewals, and anticipated cost savings. The company expects to maintain performance in line with its full-year guidance, with no specific numeric targets provided but a clear indication of continued strategic execution and financial stability.
Additional News
On September 3, 2025, Nigerian pharmaceutical company Fidson signed a partnership agreement with a Japanese firm to boost drug production, signaling potential growth in the healthcare sector. In politics, former Kaduna State Governor Nasir El-Rufai and six African Democratic Congress (ADC) leaders were invited for questioning over allegations of criminal conspiracy, highlighting ongoing political tensions. Additionally, Nigerian customs officer Emeka Okoye completed an epic 7,000-kilometer bike ride from Nigeria to Belgium, receiving national acclaim for the journey.
John Wiley & Sons B delivered a strong earnings surprise, posting a net income of $11.70 million in Q1 2026 compared to a net loss of $1.44 million in the same period the prior year. The company also reported positive EPS of $0.22, reversing its prior-year loss of $0.03 per share. While total revenue declined slightly by 1.7% year-over-year to $396.80 million, management remains confident in its 2026 guidance, citing strong demand in AI and R&D-driven research and continued cost efficiencies.
Revenue
Total revenue for John Wiley & Sons BWLYB-- declined by 1.7% to $396.80 million in Q1 2026, compared to $403.81 million in Q1 2025.
Earnings/Net Income
John Wiley & Sons B returned to profitability in Q1 2026, reporting an EPS of $0.22, up from a loss of $0.03 per share in the prior-year period, representing an 833.3% positive change. The company also achieved a significant net income of $11.70 million, a 914.8% increase from the net loss of $1.44 million in Q1 2025, marking a strong operational turnaround.
Price Action
The stock price of John Wiley & Sons B has edged down 0.00% during the latest trading day, declined 1.05% over the most recent full trading week, and gained 2.95% month-to-date.
Post-Earnings Price Action Review
Following the earnings release, the stock demonstrated mixed price movement in the short term. Although the company delivered a strong earnings turnaround, the stock remained flat in the most recent trading day and dipped slightly during the week. However, it has shown resilience with a 2.95% gain over the past month, suggesting investor confidence in the company's strategic direction and financial recovery.
CEO Commentary
Matthew Kissner, President and CEO, emphasized the company’s strong position in the AI and R&D research sectors, highlighting Wiley’s leadership in AI licensing and a landmark AI project with a large tech company. He also noted a strategic partnership with Anthropic and key operational milestones, including successful platform launches and AI integrations. Kissner expressed confidence in the company's Fiscal 2026 outlook, citing strong demand indicators, recurring revenue growth, and ongoing cost savings as key drivers.
Guidance
Wiley reaffirmed its Fiscal 2026 outlook, citing strong demand, positive output indicators, successful 2025 journal renewals, and anticipated cost savings. The company expects to maintain performance in line with its full-year guidance, with no specific numeric targets provided but a clear indication of continued strategic execution and financial stability.
Additional News
On September 3, 2025, Nigerian pharmaceutical company Fidson signed a partnership agreement with a Japanese firm to boost drug production, signaling potential growth in the healthcare sector. In politics, former Kaduna State Governor Nasir El-Rufai and six African Democratic Congress (ADC) leaders were invited for questioning over allegations of criminal conspiracy, highlighting ongoing political tensions. Additionally, Nigerian customs officer Emeka Okoye completed an epic 7,000-kilometer bike ride from Nigeria to Belgium, receiving national acclaim for the journey.

Get noticed about the list of notable companies` earning reports after markets close today and before markets open tomorrow.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet